| 肥大细胞增生症病因与治疗研究进展 |
| |
| 引用本文： | 岳万波,徐倩玥,余红.肥大细胞增生症病因与治疗研究进展[J].中国麻风皮肤病杂志,2019,35(8):505-508. |
| |
| 作者姓名： | 岳万波 徐倩玥 余红 |
| |
| 作者单位： | 上海交通大学医学院附属新华医院皮肤科,200092 |
| |
| 摘 要： | 2016年WHO更新了肥大细胞增生症(mastocytosis,MC)的分型和诊断标准,一些方法已经得到验证并应用于临床,包括:酪氨酸激酶抑制剂,单克隆抗体靶向治疗,细胞减灭术,造血干细胞移植等。本文对该病的分型、发病机制、目前常用和新兴治疗方法进行综述。
|
| 关 键 词： | 肥大细胞增生症 酪氨酸激酶抑制剂 靶向治疗 造血干细胞移植 |
Mastocytosis: pathogenesis and treatment |
| |
| YUE Wanbo,XU Qianyue,YU Hong.Mastocytosis: pathogenesis and treatment[J].China Journal of Leprosy and Skin Diseases,2019,35(8):505-508. |
| |
| Authors: | YUE Wanbo XU Qianyue YU Hong |
| |
| Institution: | Xinhua Hospital Affiliated to Shanghai Jiaotong University, School of Medicine, Shanghai 200092, China |
| |
| Abstract: | The classification and diagnosis of mastocytosis (MC) were renovated by WHO in 2016. Some new therapies have been used in treating MC, such as tyrosine kinase inhibitor, monoclonal antibody targeted therapy, cell reduction, hematopoietic stem cell transplantation, etc. The classification, pathogenesis, the common and new therapies are reviewed in this article. |
| |
| Keywords: | mastocytosis tyrosine kinase inhibitor targeted therapy hematopoietic stem cell transplantation |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《中国麻风皮肤病杂志》浏览原始摘要信息 |
| 点击此处可从《中国麻风皮肤病杂志》下载免费的PDF全文 |
|
